Volcano

About Volcano

Volcano Corporation. Cardiology Systems. Volcano Corporation develops, manufactures and commercializes a broad suite of intravascular ultrasound (IVUS) and OCT (through purchase of CardioSpectra) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural heart diseases. As of September 30, 2007, we had more than 2,900 IVUS and FM consoles installed worldwide.

Read More

Our IVUS products consist of consoles that can be integrated directly into virtually any modern cath lab. In addition, we offer both phased array and rotational single-use IVUS imaging catheters and advanced functionality options such as VH™ IVUS tissue characterization. Our IVUS offerings are used by clinicians to produce a cross-sectional image of the artery and provide information on the composition and density of plaque or lesions caused by the accumulation of fat-laden cells in the inner lining of the artery. Our FM products include consoles and single-use pressure and flow guide wires. These offerings are used to gauge the impact of arterial plaque on blood flow and pressure.

Quotes about Volcano

1. “ This is an important step in demonstrating the ability of Volcano's OCT catheter to safely image coronary vessels of human patients and establishing a leadership position in advanced coronary imaging technologies. ”

   Christopher E. Banas in Volcano Corp Announces First Human Use of the Volcano Optical ...

2. “ The high resolution OCT images provide a glimpse at structural detail not seen before by other imaging modalities. We believe that OCT has the potential to identify thin-cap fibro-atheromas, clearly highlight intraluminal thrombus, and assess the complete healing of novel drug-eluting stent designs. Volcano is committed to exploring the various clinical benefits of our OCT platform through detailed data-driven study design and mutually beneficial partnerships with other therapy companies. ”

   Michel Lussier in Volcano Corp Announces First Human Use of the Volcano Optical ...

3. “ Axsun is another complementary and important transaction for Volcano as it provides us proprietary OCT technology that we believe will both accelerate our OCT product development efforts and provide us significant and sustainable competitive advantages in the invasive imaging arena. ”

   Scott Huennekens in Medical imaging company acquires Axsun Technologies for its OCT expertise

1. Mentioned In 121 Articles

2. Volcano Announces Activities at the ACC 2010

   Explore Article ptca.org (Mar 12 2010) Cardiology , Other Business News

   March 11, 2010 -- San Diego -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed t......rmediate lesions, or various combinations," commented Joe Burnett, Executive Vice President at Volcano. "Our message, however, is quite simple. Angiography alone is not enough. Multiple large studi... (Read Full Article)
   

   Comment on Article Mentions:   GE Healthcare   Siemens   Volcano

3. Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems

   Explore Article PR Newswire (Mar 12 2010) Cardiology , Other Business News

   SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed t...... of hemodynamic monitoring systems from GE, Siemens, McKesson, and Mennen. "Utilization of Volcano's physiology (functional measurement) products has grown 79% in the last year, driven primarily... (Read Full Article)
   

   Comment on Article Mentions:   GE Healthcare   Siemens   Volcano

4. Volcano Corporation Secondary Offering of ~ 1.2M Shares Current Market Cap ~ $1.2B

   Explore Article 24/7 Wall St. (Mar 9 2010) Cardiology , Other Business News

   ...ume is 990,000 shares, the market cap is $755 million, and the 52-week range is $3.78 to $10.92. Volcano Corporation (NASDAQ: VOLC) is barely lower after it filed to sell up to 1,248,669 shares of common stock at a proposed max pr... (Read Full Article)
   

   Comment on Article Mentions:   Volcano

5. Volcano Corporation Presentation at Roth Capital Partners Conference to be Webcast

   Explore Article PR Newswire (Mar 9 2010) Cardiology , Other Business News

   SAN DIEGO, March 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed t......ne includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use digital and rotational IVUS imaging catheter... (Read Full Article)
   

   Comment on Article Mentions:   Volcano   John Dahldorf

6. Volcano revenue rises, but bottom line shrinks

   Explore Article sacbee.com (Mar 5 2010) Cardiology , Other Business News

   San Diego-based medical equipment maker Volcano Corp., which operates a manufacturing facility in Rancho Cordova, saw sizable revenue gains in 2009 but ......n, or 29 cents a share, in 2008. Revenue climbed 33 percent, to $227.9 million from $171.5 million. Volcano revenue rises, but bottom line shrinks Published: Friday, Mar. 5, 2010 - 12:00 am | Page 6B San Die... (Read Full Article)
   

   Comment on Article Mentions:   Axsun Technologies   Volcano

7. Functional Measurement Functioning Well at Volcano

   Explore Article ptca.org (Mar 3 2010) Cardiology , Other Business News

   ...) and Fractional Flow Reserve (FFR -- a.k.a. "functional measurement") is manufactured by Volcano Corporation (Nasdaq: VOLC) a San Diego-based device company that announced its fourth quarter results earlier today. Function......that announced its fourth quarter results earlier today. Functional Measurement Functioning Well at Volcano fractional flow reserve To stent or not to stent? The question is more than a rhetorical one when a... (Read Full Article)
   

   Comment on Article Mentions:   Volcano

8. Volcano Slips To Loss In Q4; Provides FY10 Outlook

   Explore Article RTTNews (Mar 3 2010) Cardiology , Other Business News

   Volcano Corporation (VOLC: News ) reported a fourth-quarter net loss of $12.07 million or $0.25 per share compared to profit ......million for the quarter. The company provided financial guidance for 2010. On a consolidated basis, Volcano expects total revenues in fiscal 2010 of $277 million-$282 million. On a GAAP basis, the company ex... (Read Full Article)
   

   Comment on Article Mentions:   Volcano

9. Volcano Reports 44 Percent Increase in Fourth Quarter Revenues

   Explore Article PR Newswire (Mar 3 2010) Cardiology , Other Business News

   SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed t...... Revenues for the fourth quarter of 2009 included $5.8 million from Axsun Technologies, Inc., which Volcano acquired in the fourth quarter of 2008, and contributed $578,000 in revenues in the fourth quarter ... (Read Full Article)
   

   Comment on Article Mentions:   Axsun Technologies   Volcano   Scott Huennekens

10. Volcano Reports Revenues Of $53.9 Million In Q3 2009

    Explore Article OfficialWire (Feb 24 2010) Cardiology , Other Business News

    Volcano Corporation - Medical Equipment - Deals and Alliances Profile is an essential source for company data and infor......rtered in California, United States And More inside the report... Recent Developments Nov 05, 2009: Volcano Reports Revenues Of $53.9 Million In Q3 2009 Aug 25, 2009: Volcano Enters Into Non-exclusive, Global Resale Agreement With Siemens Healthcare Aug 04, 2009: Volcano Reports Revenues Of $54 Million In Q2 2009 Scope - Provides ... (Read Full Article)
    

    Comment on Article Mentions:   Volcano

11. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast

    Explore Article PR Newswire (Feb 24 2010) Cardiology , Other Business News

    SAN DIEGO, Feb. 24 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed t......ne includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use digital and rotational IVUS imaging catheter... (Read Full Article)
    

    Comment on Article Mentions:   Volcano   John Dahldorf   Scott Huennekens

12. Looking ahead to Volcano Corporation earnings

    Explore Article Learning Markets (Feb 23 2010) Cardiology , Other Business News

    ... ratios can be a good indication whether a company is on the right track, or headed the wrong way. Volcano Corporation (VOLC) is scheduled to release its earnings results Tuesday. The company currently has an earnings per sh... (Read Full Article)
    

    Comment on Article Mentions:   Volcano

13. Lumen Biomedical sells core product to Volcano to generate much needed cash

    Explore Article MedCity News (Feb 11 2010) Cardiology , Acquisition

    ...ing devices to boost its balance sheet as the company struggles to stay afloat in a tough economy. Volcano Corporation, a San Diego-based medical device manufacturer, purchased Lumen’s Xtract catheter for an undisclose......aid the company wanted to move out of manufacturing and focus on product development. “We saw [the Volcano deal] as a way in a tough financial market to raise much needed funds,” Healy said. “Lots of smalle... (Read Full Article)
    

    Comment on Article Mentions:   Volcano

14. Volcano Has AAA Week: Accused, Approved and Acquired

    Explore Article ptca.org (Feb 10 2010) Cardiology , Acquisition , Other Business News

    ...l for delivery with the same console in the cath lab: a variation on "see one, do one". Volcano Has AAA Week: Accused, Approved and Acquired IVUS Image Volcano Corporation (Nasdaq: VOLC) has had a pretty interesting week. Last Thursday was the low point: a 13 person jury in Massachuse... (Read Full Article)
    

    Comment on Article Mentions:   LightLab Imaging   Volcano   Axsun Technologies

15. Date Set for LightLab Damages Trial Against Volcano and Axsun - March 22, 2010

    Explore Article PR Newswire (Feb 9 2010) Cardiology , Other Business News

    ...ement of the next phase of an ongoing trial to address damages LightLab Imaging is claiming against Volcano Corporation and its wholly owned subsidiary, Axsun Technologies, Inc. After a four week trial that addressed o......ightLab. At a future date, LightLab will also be asking the Court to issue injunctions against Volcano and Axsun consistent with the jury's findings. About LightLab Imaging LightLab Imaging, Inc.,... (Read Full Article)
    

    Comment on Article Mentions:   LightLab Imaging   Axsun Technologies   Volcano

16. Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter

    Explore Article PR Newswire (Feb 9 2010) Cardiology , Other Business News

    SAN DIEGO, Feb. 9 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance tools designed t......enefits of IVUS imaging," commented Scott Huennekens, President and Chief Executive Officer of Volcano. "With Eagle Eye® Platinum, we're now providing clinicians further improvements to our ind... (Read Full Article)
    

    Comment on Article Mentions:   Volcano   Food and Drug Administration   Scott Huennekens

1-15 of 121 // 1 2 3 4 5 6 7 8 »